An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease
暂无分享,去创建一个
Sébastien Ourselin | Marc Modat | Nick C. Fox | Daniel C. Alexander | Matthew J. Clarkson | Josephine Barnes | Nick C Fox | Hubert M. J. Fonteijn | Sarah J. Tabrizi | Rachael I. Scahill | Manja Lehmann | Nicola Z. Hobbs | M. Modat | S. Ourselin | J. Barnes | D. Alexander | S. Tabrizi | R. Scahill | M. Clarkson | M. Lehmann | H. Fonteijn | N. Hobbs
[1] M Tubiana,et al. Report of the Committee on Hodgkin's Disease Staging Classification. , 1971, Cancer research.
[2] A. Convit,et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD , 2001, Neurology.
[3] Nick C Fox,et al. Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial MRI , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[4] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[5] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[6] Karl Herrup,et al. Reimagining Alzheimer's Disease—An Age-Based Hypothesis , 2010, The Journal of Neuroscience.
[7] C. Jack,et al. Ways toward an early diagnosis in Alzheimer’s disease: The Alzheimer’s Disease Neuroimaging Initiative (ADNI) , 2005, Alzheimer's & Dementia.
[8] Bruce Fischl,et al. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. , 2008, Brain : a journal of neurology.
[9] Anders M. Dale,et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.
[10] Jane S. Paulsen,et al. Detection of Huntington’s disease decades before diagnosis: the Predict-HD study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[11] Sébastien Ourselin,et al. An Event-Based Disease Progression Model and Its Application to Familial Alzheimer's Disease , 2011, IPMI.
[12] J. Morris,et al. The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals , 2008, Cerebral cortex.
[13] Kiralee M. Hayashi,et al. Dynamics of Gray Matter Loss in Alzheimer's Disease , 2003, The Journal of Neuroscience.
[14] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[15] S. Fahn,et al. Huntington disease , 1979, Neurology.
[16] Nick C Fox,et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data , 2009, The Lancet Neurology.
[17] N. Schuff,et al. Comparison of methods for measuring longitudinal brain change in cognitive impairment and dementia , 2003, Neurobiology of Aging.
[18] R. Woods,et al. Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. , 2001, Cerebral cortex.
[19] Ian Korf,et al. Gene finding in novel genomes , 2004, BMC Bioinformatics.
[20] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[21] Lawrence R. Rabiner,et al. A tutorial on hidden Markov models and selected applications in speech recognition , 1989, Proc. IEEE.
[22] Sébastien Ourselin,et al. Fast free-form deformation using graphics processing units , 2010, Comput. Methods Programs Biomed..
[23] Heikki Mannila,et al. Seriation in Paleontological Data Using Markov Chain Monte Carlo Methods , 2006, PLoS Comput. Biol..
[24] Jane S. Paulsen,et al. Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.
[25] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[26] Nick C Fox,et al. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study , 2006, The Lancet Neurology.
[27] Nick C Fox,et al. Relationship between CAG repeat length and brain volume in premanifest and early Huntington’s disease , 2009, Journal of Neurology.
[28] D. Rubin,et al. Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .
[29] N. Schuff,et al. Higher atrophy rate of entorhinal cortex than hippocampus in AD , 2004, Neurology.
[30] Chris Frost,et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis , 2011, The Lancet Neurology.
[31] Vincent A Magnotta,et al. Longitudinal change in regional brain volumes in prodromal Huntington disease , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[32] Stuart I. Herbert,et al. Computer Methods and Programs in Biomedicine 48 (1995) 21-26 , 1995 .
[33] A. Dale,et al. Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.
[34] Sylvia Richardson,et al. Markov Chain Monte Carlo in Practice , 1997 .
[35] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[36] R. Tanzi,et al. The Genetics of Alzheimer Disease: Back to the Future , 2010, Neuron.
[37] Nikos Makris,et al. Automatically parcellating the human cerebral cortex. , 2004, Cerebral cortex.
[38] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.